Coronavirus disease 2019 (COVID-19) has become a worldwide outbreak, and it can cause various complications. However, pneumothorax secondary to COVID-19 is relatively uncommon. We herein report a 60-year-old man with bilateral refractory pneumothorax with severe COVID-19. In patients with poor general health to undergo surgery for pneumothorax post COVID-19, internal treatments such as chest drainage, bronchial occlusion and pleurodesis are essential to relieving refractory pneumothorax. It also indicates that autologous blood patch pleurodesis is a useful method in terms of efficacy and side effects.